Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soon after vaccination, the majority of vaccinees shed polioviruses with a high frequency of such mutations (Evans et al., 1985, Stern et al., 2017), indicating that the structural stability of domV is under strong positive selection in the human gut.”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Evans et al., 1985
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
The complete nucleotide sequence of a common cold virus: human rhinovlrus 14
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7859 · Cited by 254
Self-citationStanway, G., Hughes, P. J., Mountford, R. C., Reeve, P., Minor, P. D., Schild, G. C., & Almond, J. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1539 · Cited by 188
Self-citationSome simple computational methods to improve the folding of large RNAs
Jacobson, A. B., Good, L., Simonetti, J., & Zuker, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.45 · Cited by 164
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 149
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. A., Schild, G. C., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7787 · Cited by 146
Self-citationCritical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3
Evans, D. M. A., Minor, P. D., Schild, G., & Almond, J. W. (1983) · Nature · doi:10.1038/304459a0 · Cited by 111
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citation
Research works printed but not linked: 2
- Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
- Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Cited by
Grubman, M. J., & Baxt, B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.465-493.2004 · Cited by 1,840
“virulence of other picornaviruses (152, 238, 285, 324, 344, 436).”
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
Martell, M., Esteban, J. I., Quer, J., Genescà, J., Weiner, A., Esteban, R., Guardia, J., & Gómez, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3225-3229.1992 · Cited by 930
An overview of the evolution of enterovirus 71 and its clinical and public health significance
McMinn, P. C. (2002) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00070-0 · Cited by 699
“Single nucleotide changes within the poliovirus IRES have been found to result in large alterations in neurovirulence [92].”
BackgroundDengue Virus Structural Differences That Correlate with Pathogenesis
Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C., & Rico-Hesse, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4738-4747.1999 · Cited by 622
“A single-nucleotide mutation in the 59 NTR of poliovirus is associated with neurovirulence (13), and attenuation was correlated with disruption of its secondary structure (45).”
BackgroundWimmer, E., Hellen, C. U. T., & Cao, X. (1993) · Annual Review of Genetics · doi:10.1146/annurev.ge.27.120193.002033 · Cited by 554
Domingo, E., Martínez-Salas, E., Sobrino, F., de la Torre, J. C., Portela, A., Ortín, J., López-Galindez, C., Pérez-Breña, P., Villanueva, N., Nájera, R., et al. (1985) · Gene · doi:10.1016/0378-1119(85)90017-4 · Cited by 503
Bull, J. J. (1994) · Evolution · doi:10.1111/j.1558-5646.1994.tb02185.x · Cited by 188
Chronic Enteroviral Meningoencephalitis in Agammaglobulinemic Patients
McKinney, R. E., Katz, S. L., & Wilfert, C. M. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.2.334 · Cited by 452
“days in the latter study [49].”
BackgroundJang, S. K., Davies, M. V., Kaufman, R. J., & Wimmer, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1651-1660.1989 · Cited by 413
One hundred years of poliovirus pathogenesis
Racaniello, V. R. (2006) · Virology · doi:10.1016/j.virol.2005.09.015 · Cited by 322
“For example, a mutation from C to U at nucleotide 472 in the IRES of poliovirus type 3 attenuates neurovirulence in primate and murine models (Evans et al., 1985; La Monica et al., 1987; Westrop et al., 1989).”
BackgroundMolecular basis of pathogenesis of FMDV
Mason, P. W., Grubman, M. J., & Baxt, B. (2003) · Virus Research · doi:10.1016/s0168-1702(02)00257-5 · Cited by 319
Kinney, R. M., Butrapet, S., Chang, G.-J. J., Tsuchiya, K. R., Roehrig, J. T., Bhamarapravati, N., & Gubler, D. J. (1997) · Virology · doi:10.1006/viro.1997.8500 · Cited by 320
“MajorPDK-53c 0.0 — determinants of attenuation have been shown to reside a (Number of deaths/16 mice per group) 1 100. in the 5*-UTR of other positive-stranded viruses, including b —, not applicable. the Sabin poliovaccine viruses (Evans et al., 1985; Mac-c Wild-type DEN-2 16681 and PDK-53 viruses.”
BackgroundInfluentialSkinner, M. A., Racaniello, V. R., Dunn, G., Cooper, J., Minor, P. D., & Almond, J. W. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90261-1 · Cited by 297
Self-citationChen, K.-T., Chang, H.-L., Wang, S.-T., Cheng, Y.-T., & Yang, J.-Y. (2007) · Pediatrics · doi:10.1542/peds.2006-3331 · Cited by 290
Pelletier, J., Kaplan, G., Racaniello, V. R., & Sonenberg, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.3.1103 · Cited by 274
Pilipenko, E. V., Blinov, V. M., Romanova, L. I., Sinyakov, A. N., Maslova, S. V., & Agol, V. I. (1989) · Virology · doi:10.1016/0042-6822(89)90259-6 · Cited by 259
Host and virus determinants of picornavirus pathogenesis and tropism
Whitton, J. L., Cornell, C. T., & Feuer, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1284 · Cited by 252
Kawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
“cytosine) of the type 3 poliovirus genome, although this substitution apparently provides clearer and more consistent results (3) than those described here.”
BackgroundResultGenetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
Westrop, G. D., Wareham, K. A., Evans, D. M., Dunn, G., Minor, P. D., Magrath, D. I., Taffs, F., Marsden, S., Skinner, M. A., & Schild, G. C. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1338-1344.1989 · Cited by 233
“revertant strains and of excreted vaccine virus (2, 7).”
BackgroundInfluentialSelf-citationEngineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Brown, E. A., Day, S. P., Jansen, R. W., & Lemon, S. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5828-5838.1991 · Cited by 210
Kinney, R. M., Chang, G. J., Tsuchiya, K. R., Sneider, J. M., Roehrig, J. T., Woodward, T. M., & Trent, D. W. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1269-1277.1993 · Cited by 209
Jenkins, O., Booth, J. D., Minor, P. D., & Almond, J. W. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-7-1835 · Cited by 204
Self-citationLindberg, A. M., Stålhandske, P. O. K., & Pettersson, U. (1987) · Virology · doi:10.1016/0042-6822(87)90435-1 · Cited by 198
Imported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Enterovirus 71 Outbreaks, Taiwan: Occurrence and Recognition
Lin, T.-Y., Twu, S.-J., Ho, M.-S., Chang, L.-Y., & Lee, C.-Y. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0903.020285 · Cited by 196
“As with polioviruses (16), a minor yet critical genetic change may have led to unusual neurovirulence and caused this outbreak.”
BackgroundComparative sequence analysis of the 5′ noncoding region of the enteroviruses and rhinoviruses
Rivera, V. M., Welsh, J. D., & Maizel, J. V. (1988) · Virology · doi:10.1016/0042-6822(88)90656-3 · Cited by 192
Self-citationGenetic analysis of the attenuation phenotype of poliovirus type 1
Omata, T., Kohara, M., Kuge, S., Komatsu, T., Abe, S., Semler, B. L., Kameda, A., Itoh, H., Arita, M., & Wimmer, E. (1986) · Journal of Virology · doi:10.1128/jvi.58.2.348-358.1986 · Cited by 190
Salvato, M., Borrow, P., Shimomaye, E., & Oldstone, M. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1863-1869.1991 · Cited by 187
Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA
Brinton, M. A., & Dispoto, J. H. (1988) · Virology · doi:10.1016/0042-6822(88)90468-0 · Cited by 187
Hovi, T., Huovilainen, A., Kuronen, T., Pöyry, T., Salama, N., Cantell, K., Kinnunen, E., Lapinleimu, K., Roivainen, M., Stenvik, M., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91566-7 · Cited by 186
The group B coxsackieviruses and myocarditis
Kim, K., Hufnagel, G., Chapman, N. M., & Tracy, S. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.326 · Cited by 175
Butrapet, S., Huang, C. Y.-H., Pierro, D. J., Bhamarapravati, N., Gubler, D. J., & Kinney, R. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3011-3019.2000 · Cited by 173
“Determinants of attenuation have been demonstrated to lie within the 59NC region of the Sabin polio vaccine viruses (22, 40) and Venezuelan equine encephalitis virus (33).”
BackgroundTrono, D., Andino, R., & Baltimore, D. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2291-2299.1988 · Cited by 171
“Neurovirulent revertants of the Sabin type 3 strain have been isolated from patients with vaccine-associated poliomyelitis; compared with their attenuated parental strain, they were found to have a single base substitution at position 472 of the genome (6).”
BackgroundKinney, R. M., Johnson, B. J. B., Welch, J. B., Tsuchiya, K. R., & Trent, D. W. (1989) · Virology · doi:10.1016/0042-6822(89)90347-4 · Cited by 167
Structural insights into viral IRES-dependent translation mechanisms
Lozano, G., & Martínez-Salas, E. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.04.008 · Cited by 168
“Domain V, which harbors a determinant of PV neurovirulence [46], provides the binding site for PTB partially overlapping with eIF4G and eIF4A binding sites during 48S complex assembly [17 ].”
BackgroundSutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
La Monica, N., & Racaniello, V. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2357-2360.1989 · Cited by 165
“For example, a single base change at position 472 from C in the neurovirulent P3/Leon/37 to U in the type 3 vaccine is a strong determinant of attenuation (4, 13).”
BackgroundAnalysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus
Baxt, B., Vakharia, V, Moore, D. M., Franke, A. J., & Morgan, D. O. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2143-2151.1989 · Cited by 163
“Analysis of neurovirulent and attenuated strains of poliovirus type 3 suggests that a nucleotide change in the 5' noncoding region of the genome might be related to attenuation (14, 19, 39), and in poliovirus type 1, areas in the 5' half of the genome have been implicated in virulence (1, 2).”
BackgroundMartín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160
“In the case of Sabin 3-derived viruses, the changes always involve a reversion at nucleotide 472 of the 59 NCR (U to C) (9) and one or several coding mutations in the capsid proteins that restore a defect in virus assembly caused by a mutation at capsid residue VP3-91 (22).”
BackgroundSelf-citationDual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
“Studies of the attenuated PV vaccine strains of Sabin (32) have revealed that, remarkably, some of the attenuating mutations map to a specific region in the 59 nontranslated region (59NTR) of the viral genome (6, 16, 26).”
BackgroundComplete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.
Cohen, J. I., Rosenblum, B., Ticehurst, J. R., Daemer, R. J., Feinstone, S. M., & Purcell, R. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2497 · Cited by 160
Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys
Arita, M., Shimizu, H., Nagata, N., Ami, Y., Suzaki, Y., Sata, T., Iwasaki, T., & Miyamura, T. (2005) · Journal of General Virology · doi:10.1099/vir.0.80784-0 · Cited by 167
“, 1985, 1988, 1990) and act as a ts determinant, as well as the major attenuation determinant (Bouchard et al., 1995; Christodoulou et al., 1990; Evans et al., 1985; Georgescu et al., 1995; Macadam et al., 1989, 1991; Minor, 1992; Omata et al., 1986).”
Chumakov, K., Powers, L., Noonan, K. E., Roninson, I. B., & Levenbook, I. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.199 · Cited by 161
López‐Lastra, M., RIVAS, A., & Barría, M. I. (2005) · Biological Research · doi:10.4067/s0716-97602005000200003 · Cited by 206
“In agreement with these findings, the reversion of the Sabin strains towards a pathogenic phenotype, a major cause of vaccine-associated paralytic poliomyelitis, is associated with compensatory mutations in the IRES with a concomitant recovery in secondary structure and translational activity (61, 75, 165).”
ResultShih, S., Ho, M.-S., Lin, K.-H., Wu, S.-L., Chen, Y.-T., Wu, C.-N., Lin, T., Chang, L., Tsao, K., Ning, H., et al. (2000) · Virus Research · doi:10.1016/s0168-1702(00)00162-3 · Cited by 153
Tu, Z., Chapman, N. M., Hufnagel, G., Tracy, S., Romero, J. R., Barry, W. H., Zhao, L., Currey, K. M., & Shapiro, B. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4607-4618.1995 · Cited by 149
Self-citationPicornavirus IRES elements: RNA structure and host protein interactions
Martínez-Salas, E., Francisco‐Velilla, R., Fernández-Chamorro, J., Lozano, G., & Díaz-Toledano, R. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.012 · Cited by 164
“This stem-loop harbors a major determiant of PV neurovirulence, as indicated by the mutation at position 72 found in Sabin 3 strains recovered from vaccinated patients hat developed poliomyelitis (Evans et al., 1985).”
BackgroundInactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135
Cox, N. J., Kitame, F., Kendal, A. P., Maassab, H. F., & Naeve, C. W. (1988) · Virology · doi:10.1016/s0042-6822(88)90118-3 · Cited by 131
Svitkin, Y. V., Pestova, T. V., Maslova, S. V., & Agol, V. I. (1988) · Virology · doi:10.1016/0042-6822(88)90510-7 · Cited by 132
Macadam, A. J., Arnold, C., Howlett, J., John, A., Marsden, S., Taffs, F., Reeve, P., Hamada, N., Wareham, K., Almond, J., et al. (1989) · Virology · doi:10.1016/0042-6822(89)90183-9 · Cited by 125
Self-citationMartínez-Salas, E., Sáiz, J., Dávila, M., Belsham, G. J., & Domingo, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3748-3755.1993 · Cited by 122
Lundkvist, Å., Cheng, Y., Sjölander, K. B., Niklasson, B., Vaheri, A. I., & Plyusnin, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9515-9523.1997 · Cited by 122
Stone, D. M., Dixon, P. F., & Way, K. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-6-1319 · Cited by 122
“However, other well-studied virus systems have demonstrated how readily an avirulent phenotype determined by only a few nucleotide mutations can be lost or suppressed during virus replication in vivo (Evans et al., 1985 ; Macadam et al., 1989).”
BackgroundChen, B., Lee, H.-C., Lee, K.-M., Gong, Y., & Shih, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00261 · Cited by 132
Svitkin, Y. V., Cammack, N., Minor, P. D., & Almond, J. W. (1990) · Virology · doi:10.1016/0042-6822(90)90190-3 · Cited by 116
Self-citationSalvato, M. S., Shimomaye, E. M., Southern, P. J., & Oldstone, M. B. A. (1988) · Virology · doi:10.1016/0042-6822(88)90566-1 · Cited by 116
Cell‐specific proteins regulate viral RNA translation and virus‐induced disease
Pilipenko, E. V., Viktorova, E. G., Guest, S. T., Agol, V. I., & Roos, R. P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6899 · Cited by 113
Intertypic genomic rearrangements of poliovirus strains in vaccinees
Cammack, N. C., Phillips, A., Dunn, G., Patel, V., & Minor, P. D. (1988) · Virology · doi:10.1016/0042-6822(88)90113-4 · Cited by 111
Self-citationIizuka, N., Kohara, M., Hagino-Yamagishi, K., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5354-5363.1989 · Cited by 107
“A single base change at position 472 in the 5'-untranslated region of type 3 poliovirus was also correlated with the attenuation phenotype of this strain (7).”
BackgroundMerrill, M. K., & Gromeier, M. (2006) · Journal of Virology · doi:10.1128/jvi.00243-06 · Cited by 109
“neurovirulence attenuation (8, 22, 37), and deliberate manip-”
BackgroundChambers, P., Millar, N. S., Bingham, R. W., & Emmerson, P. T. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-3-475 · Cited by 107
Christodoulou, C., Colbère-Garapin, F., Macadam, A. J., Taffs, L. F., Marsden, S. A., Minor, P. D., & Horaud, F. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4922-4929.1990 · Cited by 106
Self-citationDunn, J. J., Chapman, N. M., Tracy, S., & Romero, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4787-4794.2000 · Cited by 111
“The attenuating mutations in the PV vaccine strains readily revert in passage in the human gut, largely reacquiring the virulent phenotype in the process (12).”
BackgroundBassel‐Duby, R., Spriggs, D. R., Tyler, K. L., & Fields, B. N. (1986) · Journal of Virology · doi:10.1128/jvi.60.1.64-67.1986 · Cited by 106
Macadam, A. I., Pollard, S., Ferguson, G. L., Dunn, G., Skuce, R., Almond, J. W., & Minor, P. D. (1991) · Virology · doi:10.1016/0042-6822(91)90877-e · Cited by 105
Self-citationRNA virus evolution and the control of viral disease
Domingo, E. (1989) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9146-2_5 · Cited by 117
The 5′-Untranslated Region of Picornaviral Genomes
Agol, V. I. (1991) · Advances in virus research · doi:10.1016/s0065-3527(08)60278-x · Cited by 112
“This suspicion was greatly reinforced by the discovery that reversion to neurovirulence of the Sabin type 3 vaccine strain was often accompanied by a back mutation in position 472 (Cann et al., 1984; Evans et al., 1985); thus, the neurovirulent parent and revertants have a C residue at this position, whereas the atten…”
BackgroundTebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
“(107) Viruses isolated from type 3 VAPP cases show the reversion of nt position 472 and exhibit high neurovirulence in monkey tests.(120) Type 3 viruses isolated from an immunodeficient patient (i.”
BackgroundCommon structures of the 5′ non-coding RNA in enteroviruses and rhinoviruses
Le, S., & Zuker, M. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90395-3 · Cited by 99
Enterovirus/Picornavirus infections
Jubelt, B., & Lipton, H. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00018-3 · Cited by 116
Intracellular determinants of picornavirus replication
Andino, R., Böddeker, N., Silvera, D., & Gamarnik, A. V. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01446-2 · Cited by 100
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus
Clarke, B. E., Brown, A. L., Currey, K. M., Newton, S. E., Rowlands, D. J., & Carroll, A. R. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.17.7067 · Cited by 98
Self-citationFong, T., Lee, S. R., Briggs, W., Valinluck, B., Govindarajan, S., Hoffman, A., Jaczko, B., & Redeker, A. G. (1996) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199607)49:3<161::aid-jmv2>3.0.co;2-2 · Cited by 14
Horie, H., Koike, S., Kurata, T., Sato-Yoshida, Y., Ise, I., Ota, Y., Abe, S., Hioki, K., Kato, H., & Taya, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.681-688.1994 · Cited by 96
Arita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95
“Cambodia-02 had reversions at the major attenuation determinants of Sabin 3 at nt 472 (U to C) and nt 2034, which resulted in an amino acid change of VP3 Phe91 to Ser (13, 31) (Fig.”
BackgroundChapter 1 The Pathogenesis of Poliomyelitis: What We Don't Know
Nathanson, N. (2008) · Advances in Virus Research · doi:10.1016/s0065-3527(08)00001-8 · Cited by 95
Meerovitch, K., Nicholson, R., & Sonenberg, N. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5895-5901.1991 · Cited by 95
The Nucleotide Sequence of Human Rhinovirus 1B: Molecular Relationships within the Rhinovirus Genus
Hughes, P. J., North, C., Jellis, C. H., Minor, P. D., & Stanway, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-1-49 · Cited by 95
“Interestingly, in poliovirus type 3 a single mutation in the vicinity of one of the blocks (position 472) has been shown to exert a marked effect on the virulence of different strains (Evans et al., 1985).”
BackgroundSelf-citationBlomqvist, S., Bruu, A., Stenvik, M., & Hovi, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18708-0 · Cited by 110
“This substitution is found often in vaccine strains isolated from healthy vaccinees and VAPP cases, consistent with rapid reversion of this nucleotide in the human gut (Evans et al. , 1985; Minor & Dunn, 1988).”
Bailey, J. M., & Tapprich, W. E. (2006) · Journal of Virology · doi:10.1128/jvi.01327-06 · Cited by 109
“Domain V has received a great deal of experimental attention because the attenuation mutations for the vaccine strains of poliovirus are located in this domain (17, 40).”
BackgroundGenome-wide diversity and selective pressure in the human rhinovirus
Kistler, A. L., Webster, D. R., Rouskin, S., Magrini, V. J., Credle, J. J., Schnurr, D. P., Boushey, H. A., Mardis, E. R., Li, H., & DeRisi, J. L. (2007) · Virology Journal · doi:10.1186/1743-422x-4-40 · Cited by 99
“Such differences are of particular interest as these elements have been shown to be essential for viral replication, translation, overall viability, and in the case of poliovirus, for pathogenicity and tissue tropism [72-75].”
BackgroundMcKnight, K. L., Simpson, D. A., Lin, S. C., Knott, T. A., Polo, J. M., Pence, D. F., Johannsen, D. B., Heidner, H. W., Davis, N., & Johnston, R. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1981-1989.1996 · Cited by 98
Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA
Haller, A. A., & Semler, B. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5075-5086.1992 · Cited by 91
“The mutations X472, X478, and X482 are located in a region thought to contain determinants for the attenuation and/or neurovirulence phenotype of poliovirus (8, 33).”
BackgroundMacadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
“genetically unstable as the virus replicates in recipients (5, 7, 8).”
BackgroundSelf-citationBachmann, M. F., Kündig, T. M., Kalberer, C. P., Hengartner, H., & Zinkernagel, R. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3917-3922.1993 · Cited by 91
“In addition, in some instances, live vaccines may regain their virulence (5, 22).”
BackgroundRacaniello, V. R., & Meriam, C. (1986) · Virology · doi:10.1016/0042-6822(86)90211-4 · Cited by 89
The quasispecies of hepatitis C virus and the host immune response
Farci, P., Bukh, J., & Purcell, R. H. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00945022 · Cited by 89
“A specific nucleotide change in Sabin type-3 poliovirus vaccine strain was associated with an increase in neurovirulence [26].”
BackgroundPoliovirus tropism and attenuation are determined after internal ribosome entry
Kauder, S. E., & Racaniello, V. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421323 · Cited by 83
“The C472U mutation within the IRES of the Sabin type 3 vaccine strain attenuates neurovirulence (23) and was shown to cause a translation defect in vitro (28).”
Rodríguez‐Cerezo, E., Klein, P. G., & Shaw, J. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9863 · Cited by 87
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans
Monica, N. L., Almond, J. W., & Racaniello, V. R. (1987) · Journal of Virology · doi:10.1128/jvi.61.9.2917-2920.1987 · Cited by 83
“Perhaps the secondary structure of the region, which appears to be altered by the mutation at position 472 (4), is important.”
BackgroundSelf-citationPevear, D. C., Borkowski, J. A., Calenoff, M. A., Oh, C. K., Ostrowski, B., & Lipton, H. L. (1988) · Virology · doi:10.1016/0042-6822(88)90652-6 · Cited by 83
Oncolytic polio virotherapy of cancer
Brown, M. C., Dobrikova, E. Y., Dobrikov, M. I., Walton, R. W., Gemberling, S. L., Nair, S. K., Desjardins, A., Sampson, J. H., Friedman, H. S., Friedman, A. H., et al. (2014) · Cancer · doi:10.1002/cncr.28862 · Cited by 82
“1B).(32) Later investigations linked the Sabin-attenuating IRES mutations to compromised neuronal translation initiation.”
BackgroundBasic rationale, current methods and future directions for molecular typing of human enterovirus
Nasri, D., Bouslama, L., Pillet, S., Bourlet, T., Aouni, M., & Pozzetto, B. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.4.419 · Cited by 98
The Attenuation Of Poliovirus Neurovirulence
Almond, J. W. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.001101 · Cited by 82
Self-citationYan, J., Su, I., Chen, P., Liu, C., Yu, C., & Wang, J. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2038 · Cited by 81
“The variations in the sequence and structure of the 50-NCR have been correlated to the neurovirulence of polioviruses [Evans et al., 1985; Macadam et al., 1989; Chumakov et al., 1992].”
Yeh, M. T., Wang, S.-W., Yu, C., Lin, K.-H., Lei, H.-Y., Su, I. J., & Wang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027082 · Cited by 82
“Nucleotide 480, 481 and 472 which attenuates neurovirulence of poliovirus Type 1, 2 and 3, reduces viral translation in neuronal cells [23,24,38].”
Background
Metadata
- Authors
- Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- University of Leicester (GB)
- National Institutes of Health (US)
- ORCID
- Cann, A. J.
- Venue
- Nature
- Published
- 1985-04
- Volume
- 314
- Issue
- 6011
- Pages
- 548-550
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044967254
- Cited by
- 440
- References
- 17
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 7 · 2012: 3
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-associated poliomyelitis, neurovirulence, point mutations, 5' untranslated region, genetic reversion, vaccine strain selection
- MeSH terms
- Base Sequence, DNA, Viral, Feces, Genes, Viral, Humans, Infant, Mutation, Nucleic Acid Conformation, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Structure-Activity Relationship, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.